In April 2026, Health Canada approved the first generic versions of semaglutide injections. Dr. Reddy’s Laboratories received authorization for a 2 mg/1.5 mL and a 4 mg/3 mL pen device for once-weekly injection. In May 2026, a second generic from Apotex was approved. These generics are described by Health Canada as pharmaceutically equivalent to the reference product.
Semaglutide is not a quick-fix diet pill. Unlike herbal supplements that claim to boost metabolism, semaglutide mimics a naturally occurring hormone (GLP-1) that regulates insulin secretion, slows stomach emptying, and triggers feelings of fullness. Because of its powerful effects, regulatory bodies treat it as a prescription drug.
Why semaglutide requires a prescription in Canada
Health Canada is the federal authority that evaluates and approves all medications in Canada. When a new drug shows it is safe, effective, and of standards, it is added to the Prescription Drug List. Drugs on this list can only be sold under the supervision of a licensed healthcare provider.
Once Health Canada classifies a medication as prescription-only, it must be sold by prescription in all provinces and territories.
Prescription status of brand and generic semaglutide
Health Canada’s regulatory decision summary for Ozempic clearly states that the product is a Schedule D drug, meaning it is available by prescription only. Generic versions from Dr. Reddy’s and Apotex were approved under the condition that they are used for once-weekly treatment of adults with type 2 diabetes and are available only by prescription.
The National Association of Pharmacy Regulatory Authorities (NAPRA) explains that once a drug appears on Health Canada’s Prescription Drug List, pharmacists must require a valid prescription before dispensing it.
Unlike over-the-counter products such as acetaminophen, semaglutide cannot be purchased legally without a doctor’s or nurse practitioner’s authorization. This classification applies equally to generic and brand versions.
Do you need a prescription for generic semaglutide in Canada?
Yes. Semaglutide is a prescription medication. Patients seeking semaglutide through Canadian pharmacies are generally required to provide a valid prescription from a licensed healthcare provider. Prescription requirements, pharmacy policies, and dispensing practices may vary depending on the pharmacy and jurisdiction.
This requirement applies equally to brand-name Ozempic and Wegovy as well as generic semaglutide. The regulatory summaries of both brand and generic products emphasize that they are prescription-only.
Some people assume that because generic medications are cheaper and widely available, they can be purchased without a prescription. However, the active ingredient, potency, and potential risks remain the same, so generics fall under the same regulatory controls.
Pharmacists who dispense semaglutide without a prescription could face regulatory penalties.
Cross-border considerations for US residents
US residents sometimes travel to Canada or order from Canadian pharmacies seeking lower drug prices. US law allows individuals to import a limited supply of certain prescription drugs from Canada for personal use under specific circumstances, but the process still requires a legitimate prescription. Customs officials may seize shipments that lack proper documentation.
Who is eligible for a semaglutide prescription?
Semaglutide is not appropriate for everyone. Health professionals consider a range of factors when deciding whether to prescribe it. Below are general criteria, and individual circumstances may vary. Always consult a healthcare provider.
Eligibility for Type 2 Diabetes
For people with Type 2 diabetes, semaglutide is often considered after diet, exercise, and first-line medications like metformin have been tried. Doctors may prescribe semaglutide when:
-
- HbA1c remains above target despite first-line therapy or when metformin is contraindicated or not tolerated.
-
- Cardiovascular risk is high. Semaglutide has been shown to reduce the risk of major cardiovascular events in patients with Type 2 diabetes and established cardiovascular disease.
-
- Weight reduction is beneficial. Many people with Type 2 diabetes also struggle with obesity, and semaglutide’s weight-loss effect can help.
Canadian Diabetes guidelines encourage individualized therapy. Patients with kidney disease, pancreatitis, severe gastrointestinal disorders, or a history of diabetic ketoacidosis require special consideration. Because generic semaglutide is currently only approved for Type 2 diabetes, clinicians will use similar criteria for prescribing it.
Eligibility for weight management (Wegovy and off-label semaglutide)
For chronic weight management, Wegovy is approved for adults with a BMI of at least 30 kg/m² or 27 kg/m² with at least one weight-related condition, such as:
-
- hypertension
- type 2 diabetes
- dyslipidemia
- obstructive sleep apnea
Off-label use of Ozempic for weight loss may follow similar criteria but should occur under the guidance of an experienced obesity medicine physician. Importantly, pharmacotherapy is usually considered after structured lifestyle interventions have been attempted.
Exclusions and contraindications
Semaglutide is contraindicated in certain situations. The US FDA label warns that individuals with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2) should not take semaglutide.
The drug carries a boxed warning about thyroid C-cell tumors and instructs prescribers to counsel patients about the risk. Additional caution is advised for people with a history of pancreatitis, gallbladder disease, diabetic retinopathy, or severe kidney problems. Semaglutide is not recommended during pregnancy or breastfeeding.
Pre-operative considerations
The Institute for Safe Medication Practices (ISMP) Canada published a bulletin warning that semaglutide can delay gastric emptying, which may increase the risk of aspiration during anesthesia.
The bulletin recommends holding semaglutide for at least three half-lives (7 days per half-life) before elective surgery or procedures requiring anesthesia. Discuss any upcoming surgeries with your prescriber.
How to get a semaglutide prescription
You must work with a healthcare provider who evaluates your medical history, confirms eligibility, and monitors ongoing use. Here are common pathways:
Visiting a family doctor or specialist
-
- Book an appointment – Schedule a consultation with your family physician, endocrinologist, or obesity specialist. If you do not have a regular doctor, contact a walk-in clinic or community health center.
- Assessment – During the appointment, discuss your health goals, medical history, current medications, and prior weight-loss attempts. The provider may order blood tests (e.g., HbA1c, kidney function), measure BMI, and check blood pressure.
- Discuss options – Your provider will explain the benefits and risks of semaglutide versus other therapies. If you meet eligibility criteria and there are no contraindications, they may prescribe a suitable product (e.g., Ozempic, Wegovy, or a generic).
- Prescription and monitoring – You’ll receive a prescription that can be filled at a pharmacy. Follow-up appointments are important to monitor efficacy, adjust dosing, and manage side effects.
Telehealth and virtual clinics
Telemedicine has grown rapidly, especially since the COVID-19 pandemic. Many telehealth platforms now connect patients with licensed healthcare providers who can evaluate them remotely.
Typically, this involves completing an online questionnaire, followed by a review from a clinician who may request additional information or a virtual consultation. If appropriate, the provider can issue a prescription that is sent to a local pharmacy or delivered by mail. This model can significantly reduce wait times, especially if you don’t have a regular primary care provider.
Telehealth providers are still required to follow the same medical and legal standards as in-person clinicians, including verifying patient identity, conducting an appropriate medical assessment, and obtaining informed consent. They cannot legally prescribe semaglutide unless you meet established clinical criteria.
However, not all telehealth services operate with the same level of transparency. Some platforms may advertise compounded semaglutide as a generic version. Compounded semaglutide is not the same as an approved generic and may vary in quality, safety, and effectiveness.
In some instances, these formulations may use different salt forms or inactive ingredients that have not been thoroughly studied. It’s important to verify whether the medication being offered is FDA-approved and dispensed through a licensed pharmacy. When in doubt, ask the provider directly about the source and formulation of the medication before proceeding.
Off-label prescribing and private weight-loss clinics
Demand for GLP-1 drugs has created a market for private weight-loss clinics offering semaglutide injections for high fees. Experts cautioned that some providers were prescribing semaglutide without seeing patients in person during supply shortages. Prescribers must personally assess patients and use clinical judgment when prescribing off-label.
Legitimate clinics often require an initial consultation and ongoing monitoring. Verify that providers are licensed, and be wary of services that promise semaglutide without proper evaluation.
How Americans can buy generic semaglutide from Canada online
You can easily follow our standard online ordering process.
Step 1. Search for “Generic semaglutide”
Use the search bar at the top of the website to search for “generic semaglutide.” Once you’re on the product page, select your prescribed dose (0.25 mg, 0.5 mg, or 1 mg) and click “Add to Cart.”
If you’d like to add additional medications, simply use the search bar to find them and add them to your cart. We carry a wide range of GLP-1 medications, including brand-name Ozempic, Wegovy, Mounjaro, and Zepbound. We also offer pen needles compatible with generic semaglutide pens.
Once you’ve added all of your medications and supplies, click the “Cart” button in the upper-right corner of the screen to proceed to checkout.
Step 2. Complete secure checkout
Once your cart is complete, proceed to checkout. Enter your contact details, payment information, and shipping address.
New customers will need to create an account using an email address and password. Remember to save 10% on your first order using coupon code FIRST10. Existing customers can log in with their current account details.
After submitting the order, you should receive a confirmation email.
Step 3. Upload, email, or fax your prescription
For prescription medications, we require a valid prescription before the order can be processed. You can send your prescription in one of three ways.
-
- Upload it directly on the website using the RX document uploader after placing your order.
- Email a clear scanned copy or photo of your prescription to info@buycanadianinsulin.com.
- Fax your prescription to 1-888-234-1275.
If your prescription is not on file when the team reviews your prescription order, BuyCanadianInsulin.com may contact you to request the required documentation.
Step 4. Wait for your generic Ozempic to arrive
Once a pharmacist reviews your order, eligible prescription orders can be processed for delivery. Tracking information is emailed when available so you can follow your shipment.
Bottom line
If you think semaglutide might be right for you, consult a healthcare provider who can assess your condition and medical history. They can determine whether you meet eligibility criteria for type 2 diabetes or chronic weight management, explain the benefits and risks, and guide you through dose escalation and follow-up. Telehealth platforms can be useful when access to a doctor is limited.
Once you receive your prescription, you can order generic semaglutide for just $199.99 per pen, or save even more with a 3-month supply for $570.
Frequently Asked Questions
Articles you may also be interested in
Sources
Jones, T. (2025, November 7). Drug scheduling in Canada. NAPRA. https://www.napra.ca/national-drug-schedules/drug-scheduling-in-canada/
ISMP Canada. (2023). Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Risk of Aspiration during Anesthesia. https://ismpcanada.ca/wp-content/uploads/ISMPCSB2023-i9-GLP-1.pdf
Health Canada. (2026, April 28). Canada becomes the first G7 country to approve a generic version of semaglutide. Canada.ca. https://www.canada.ca/en/health-canada/news/2026/04/canada-becomes-the-first-g7-country-to-approve-a-generic-version-of-semaglutide.html
Health Canada. (2026, May 1). Canada approves second generic semaglutide, the first G7 country to do so. Canada.ca. https://www.canada.ca/en/health-canada/news/2026/05/canada-approves-second-generic-semaglutide-the-first-g7-country-to-do-so.html
